How early? ASAP: Molecular and functional imaging!

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 34, Issue 4, 2007, Pages 596-601

  Lucignani, Giovanni ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; AMYLOID BETA PROTEIN; ANGIOGENESIS INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; FLUORODEOXYGLUCOSE; GEFITINIB; GLUCOSE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PRESENILIN 1; YTTRIUM 90;

ACUTE HEART INFARCTION; ALZHEIMER DISEASE; B CELL LYMPHOMA; BRAIN ATROPHY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL TRIAL; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; EARLY DIAGNOSIS; ESOPHAGUS CANCER; GENE MUTATION; GLUCOSE METABOLISM; HOSPITAL DISCHARGE; HUMAN; LIVER TUMOR; MEDICAL DECISION MAKING; MOLECULAR IMAGING; NEUROFIBRILLARY TANGLE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; REVIEW;

HUMANS; IMAGE ENHANCEMENT; PHYSICIAN'S PRACTICE PATTERNS; RADIOISOTOPES; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS;

EID: 33947235579     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0381-x     Document Type: Review

References (14)

1. http://www.m-w.com/dictionary/early
2. Mosconi L, Sorbi S, de Leon MJ, Li Y, Nacmias B, Myoung PS, et al. Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. J Nucl Med 2006;47 11:1778-86.
3. Mondadori CR, Buchmann A, Mustovic H, Schmidt CF, Boesiger P, Nitsch RM, et al. Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years. Brain 2006;129 Pt 11:2908-22.
4. Small GW, Kepe V, Ercoli LM, Siddarth P, Bookheimer SY, Miller KJ, et al. PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med 2006;355 25:2652-63.
5. Juweid ME, Cheson BD. Positron-emission tomography and assessment of cancer therapy. N Engl J Med 2006;354 5:496-507.
6. Su H, Bodenstein C, Dumont RA, Seimbille Y, Dubinett S, Phelps ME, et al. Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitors. Clin Cancer Res 2006;12 19:5659-67.
7. Linden HM, Krohn KA, Livingston RB, Mankoff DA. Monitoring targeted therapy: is fluorodeoxylucose uptake a marker of early response? Clin Cancer Res 2006;12 19:5608-10.
8. Chaise C, Itti E, Petegnief Y, Wirquin E, Copie-Bergman C, Farcet JP, et al. [F-18]-Fluoro-2-deoxy-D: -glucose positron emission tomography as a tool for early detection of immunotherapy response in a murine B cell lymphoma model. Cancer Immunol Immunother DOI 10.1007/s00262-006-0265-02006 (Epub ahead of print).
9. Kostakoglu L, Goldsmith SJ, Leonard JP, Christos P, Furman RR, Atasever T, et al. FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease. Cancer 2006;107 11:2678-87.
10. Rousseau C, Devillers A, Sagan C, Ferrer L, Bridji B, Campion L, et al. Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F] fluorodeoxyglucose positron emission tomography. J Clin Oncol 2006;24 34:5366-72.
11. 90Y microspheres: Value of FDG PET versus computed tomography. Nucl Med Commun 2007;28 1:15-20.
12. Mulder WJ, van der Schaft DW, Hautvast PA, Strijkers GJ, Koning GA, Storm G, et al. Early in vivo assessment of angiostatic therapy efficacy by molecular MRI. FASEB J Jan. 2007 (Epub ahead of print).
13. Jingu K, Kaneta T, Nemoto K, Ichinose A, Oikawa M, Takai Y, et al. The utility of 18F-fluorodeoxyglucose positron emission tomography for early diagnosis of radiation-induced myocardial damage. Int J Radiat Oncol Biol Phys 2006;66 3:845-51.
14. Mahmarian JJ, Shaw LJ, Filipchuk NG, Dakik HA, Iskander SS, Ruddy TD, et al. INSPIRE Investigators. A multinational study to establish the value of early adenosine technetium-99m sestamibi myocardial perfusion imaging in identifying a low-risk group for early hospital discharge after acute myocardial infarction. J Am Coll Cardiol 2006;48 12:2448-57.